ABVC Biopharma Inc
ABVC
$0.91-2.84%
Delayed · as of Oct 16, 2026, 2:00 PM ET
Mkt cap
$35.88M
EV/Sales
N/A
P/E ratio
N/A
Revenue (qtr ended 2025-09-30)
$795,950
EPS (H1 2026)
$-0.09
Gross Margin (qtr ended 2025-09-30)
100.00%
Profit Margin (qtr ended 2025-09-30)
-156.61%
Beta
N/A
Div yield
N/A
Sector
Healthcare
ABVC Biopharma Inc (ABVC) is a biotechnology company listed on NASDAQ.
Latest reported ABVC revenue for 2025-09-30 was $796.0K. Net income was -$1.2M. Revenue was up 104.5% from 2024-09-30 to 2025-09-30. ABVC currently screens at market cap $35.9M.
Use this ABVC research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full ABVC income, balance, and cash tables.
† Total Debt: Derived from short-term debt only (no total or long-term debt stored).
ABVC Biopharma Inc (ABVC) is a biotechnology company in the Healthcare sector.
Latest cached ABVC Biopharma Inc (ABVC) revenue for Sep 30, 2025 was $796.0K. Net income was -$1.2M. Statements: https://lician.com/financials/abvc
ABVC Biopharma Inc (ABVC) market capitalization is $35.9M on the latest cached snapshot.
ABVC Biopharma Inc (ABVC) cached previous close $0.93; day range $0.90 – $0.95; volume 21,949. Session quote: https://lician.com/quote/abvc
ABVC Biopharma Inc (ABVC) latest cached earnings event is "ABVC earnings" on Aug 12, 2026. Earnings calendar: https://lician.com/earnings
The latest cached ABVC filing is 8-K/A · Aug 12, 2026. Filings: https://lician.com/sec/abvc